Sema4, a Mount Sinai spinout, launches with a focus on genomics
MedCity News | June 01, 2017
Pronounced “semaphore,” the company will utilize genomic and clinical data to transform overall clinical diagnostics. By combining everything from predictive modeling to open access data, it aims to be able to better treat and diagnose diseases.